Article

COVID-19 Vaccinations, Infections and Outcomes among 784 People Living with HIV

2024-09-30

Abstract excerpt

<h4>Introduction: </h4> Variants of COVID-19 are responsible for 700 million infections and 7 million deaths worldwide. Vaccinations have high efficiency in preventing infection and secondary benefits of reducing COVID-19 hospital admissions, attenuating disease severity and duration of illness. Conflicting reports were published regarding COVID-19 among PLWH. <h4>Objective:</h4> The aim of this study was to evalu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9729ddb2-a5be-55bb-8368-632ebdc9ea73
DOI: 10.20944/preprints202409.2397.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

COVID-19 Vaccinations, Infections and Outcomes among 784 People Living with HIVDOI 10.20944/preprints202409.2397.v1Read

HIV Infection is Associated with Higher Risk of Post-Acute Sequelae of SARS-CoV-2 (PASC) However Vaccination is ProtectiveSemantic proximity Read

Clinical and Virologic Factors associated with Outcomes of COVID-19 before and after Vaccination among Veterans: Retrospective Analysis from Six New England StatesSemantic proximity Read

Seroprevalence, Neutralizing Antibody Titers Following Infection, and COVID-19 Disease Severity Differ Among People With and Without HIVSemantic proximity Read

COVID-19 deaths and hospitalizations averted by rapid vaccination rollout in the United StatesSemantic proximity Read

Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1Semantic proximity Read

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine in People Living with HIV-1Semantic proximity Read

Effectiveness of 2024–2025 COVID-19 Vaccination Against COVID-19 Hospitalization and Severe In-Hospital Outcomes — IVY Network, 26 Hospitals, September 1, 2024–April 30, 2025Semantic proximity Read

Impact of SARS-CoV-2 vaccination on systemic immune responses in people living with HIVSemantic proximity Read

Effectiveness of Covid-19 Vaccines in the United States Over 9 Months: Surveillance Data from the State of North CarolinaSemantic proximity Read

Effectiveness of the 2023-2024 Omicron XBB.1.5-containing mRNA COVID-19 vaccine (mRNA-1273.815) in preventing COVID-19-related hospitalizations and medical encounters among adults in the United States: An interim analysisSemantic proximity Read

Effectiveness of the 2023–2024 Omicron XBB.1.5-containing mRNA COVID-19 Vaccine (mRNA-1273.815) in Preventing COVID-19–related Hospitalizations and Medical Encounters Among Adults in the United StatesSemantic proximity Read

COVID-19 vaccinations: The unknowns, challenges, and hopes.Semantic proximity Read